System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Frank G Holz is an expert in Ophthalmology at University Hospital Bonn (Germany). As of October 2026, ScienceLeadR ranks Frank G Holz in the top 1% of experts worldwide for Retinal Diseases, Telangiectasis and Visual Acuity. Frank G Holz has authored 1,324 publications, the most recent in 2026, and is an investigator in 30 clinical trials, 1 of them ongoing. SLR score: 3,756 (community average: 125). How the SLR is computed.

LeadR Profile

Frank G Holz University Hospital Bonn Germany
3 756 ScienceLeadR Reputation 3756

Unlock

Register Login
Network Map

Ophthalmology

Subspecialties: Surgery - Otolaryngology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026
Source: PubMed

University Hospital Bonn

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1324

Citations

Citations: 46 029 1st author: 83 Last author: 237 Unique author: 16

Main journals

Invest Ophthalmol Vis Sci 259
Ophthalmologe 143
Ophthalmologie 63
Br J Ophthalmol 58
Retina 56

Best Journals

Lancet 3
N Engl J Med 2
Nat Genet 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Long-term outcomes of the PAUL Glaucoma Implant Versus Ahmed Glaucoma Valve.
PMID 42933824 — ophthalmology, glaucoma		Br J Ophthalmol20260
Advancing automated phase recognition in cataract surgery through the SICS-155 challenge.
PMID 42777601 — phacoemulsification, work, cataract, artificial intelligence		Med Image Anal20260
Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice.
PMID 42901982 — macular degeneration, translating		Eye (Lond)20260
Automated Segmentation of Retinal Pigment Epithelium Layers in High-Resolution OCT.
PMID 42876516 — healthy volunteers, retinal pigments, retinal pigment epithelium, retinaldehyde, epithelium		Ophthalmol Sci20260
[Stargardt disease (ABCA4-asssociated retinopathy): Overview of clinical aspects, classification and differential diagnoses].
PMID 42873269 — macular degeneration, diagnosis, differential, genes, atrophy, stargardt disease, ophthalmology, classification, tomography, optical coherence, genotype, diagnosis, eye diseases, retinaldehyde		Ophthalmologie20260

Clinical Studies 30

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

N/A 14
Phase 3 6
Phase 2 4
Phase 4 4
Phase 2/Phase 3 1
Phase 3/Phase 4 1

By status:

Completed 24
Active not recruiting 2
Recruiting 2
Terminated 2

By type:

Interventional 18
Observational 12

By Monocentric/Multicentric:

monocentric 11
multicentric2to4 0
multicentric5to9 2
multicentricup10 17

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study to Assess the Injection Burden Safety Efficacy and Long Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV RGX 314) Compared to Ranibizumab in Adult Participants with Neovascular Age Related Macular Degeneration (nAMD)
2024-512298-28-00 — injections, macular degeneration, safety, ranibizumab, visual acuity		Phase 3/Phase 4Recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS